Articles, insights, and posts about Child Development, early detection, and new methods in diagnosis and treatment.
San Diego, CA – The FDNA team is excited to be back at the American Society of Human Genetics (ASHG) Annual Meeting, October 16-20 in San Diego and tell you more about how Face2Gene facilitates the sharing of phenotypic information with labs for improved NGS analysis. To learn more, attend our exhibitor education event, swing […]
Change in healthcare comes in many forms. Some say it’s legislature. Some say it’s technology. Some will cite time and patience–but those with an inside view on rare disease advocacy know that the driving force behind change usually comes in the shape of a mother who has just been told her child’s life will never […]
ThinkGenetic recently hosted a panel discussion among researchers involved in the Genomics Collaborative, an FDNA initiative connecting researchers, clinicians, patients, laboratories, and advocacy groups to further disease discovery. Panel members presented their work with the collaborative, followed by a Q&A session moderated by Dawn Laney, all of which is available to watch at the bottom […]
FDNA’s CEO Dekel Gelbman recently spoke to hundreds of leaders during the Stanford Big Data in Precision Health Summit. The article below is based on the information he presented at the conference. By now, AI is so commonplace it’s almost embarrassing if a tech company doesn’t use it. But as much as the sci-fi world […]
Big data, next-generation phenotyping, and the possibilities for precision medicine This post is based on a presentation given at the Precision Medicine World Conference. You can skip to the video by clicking here. As researchers and clinicians expand their investigation of the relationship between phenotypes and genotypes, the importance of accurate phenotypic analysis grows. That […]
A flock of researchers from around the globe shared their findings in dysmorphology and molecular genetics at this year’s ESHG as a part of FDNA’s corporate satellite talk and various scientific posters. Karin Weiss (Rambam Health Care Campus, Haifa, Israel) presented her further work on Sifrim Hitz Weiss Syndrome (SIHIWES), a recently described form […]
The European Society of Human Genetics (ESHG) 42nd Annual Meeting 2018 MiCo – Milano Congressi · Milan, Italy · June 16-19, 2018 Milan, Italy – I don’t know about you, but here at FDNA, we are extremely excited for an action-packed week full of presentations, posters, meetings, and, of course, gelato! Take a look […]
“When you talk about precision medicine every disease can become somewhat of a rare disease because you’re going to increasingly segment down the different subtypes of that disease.” That’s host Simon Smith’s takeaway from the inaugural episode of BenchSci’s Artificial Intelligence in Drug Discovery podcast, a show offering knowledge and inspiration from leaders in the […]
Artificial intelligence has increasingly become the basis for advancing precision medicine. Tomorrow, at the ReWork Deep Learning in Healthcare Summit in Boston, MA, FDNA CEO Dekel Gelbman will be featured among other thought leaders—Cansu Canca, Founder and Director of the AI Ethics Lab, and Adrian Gropper, CTO at Patient Privacy Rights—to discuss balancing ethics and […]